Landscape Capital Management, L.L.C. Natera, Inc. Transaction History

Landscape Capital Management, L.L.C.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$28.13 - $44.54 $1.19 Million - $1.89 Million	-42,437 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$30.32 - $91.33 $308,415 - $929,008	10,172 Added 31.53%	42,437 $1.73 Million
Q4 2021 Feb 01, 2022	SELL	$86.26 - $119.0 $411,201 - $567,273	-4,767 Reduced 12.87%	32,265 $3.01 Million
Q3 2021 Nov 09, 2021	BUY	$100.17 - $126.36 $414,403 - $522,751	4,137 Added 12.58%	37,032 $4.13 Million
Q2 2021 Aug 03, 2021	BUY	$86.05 - $119.72 $73,830 - $102,719	858 Added 2.68%	32,895 $3.74 Million
Q1 2021 May 11, 2021	BUY	$91.47 - $124.36 $1.85 Million - $2.51 Million	20,202 Added 170.7%	32,037 $3.25 Million
Q4 2020 Feb 09, 2021	BUY	$66.66 - $111.74 $788,921 - $1.32 Million	11,835 New	11,835 $1.18 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.